SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-069538
Filing Date
2023-08-22
Accepted
2023-08-21 18:06:56
Documents
13
Period of Report
2023-08-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT DATED AUGUST 17, 2023 ea183972-8k_oramedpharm.htm   iXBRL 8-K 34544
2 SECOND AMENDMENT TO STOCK PURCHASE AGREEMENT DATED AS OF AUGUST 21, 2023, BETWEE ea183972ex2-3_oramed.htm EX-2.3 27061
  Complete submission text file 0001213900-23-069538.txt   244367

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ormp-20230817.xsd EX-101.SCH 3009
4 XBRL LABEL FILE ormp-20230817_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE ormp-20230817_pre.xml EX-101.PRE 22355
7 EXTRACTED XBRL INSTANCE DOCUMENT ea183972-8k_oramedpharm_htm.xml XML 3320
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35813 | Film No.: 231190470
SIC: 2834 Pharmaceutical Preparations